Log In
Print
BCIQ
Print
Print this Print this
 

Vargatef, nintedanib (BIBF 1120)

Also known as: BIBF1120

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionSmall molecule inhibitor of multiple pro-angiogenic kinases including VEGF, PDGFR and fibroblast growth factor (FGF) receptor
Molecular Target Vascular endothelial growth factor (VEGF) receptor ; Platelet derived growth factor receptor (PDGFR)
Mechanism of ActionPlatelet derived growth factor receptor (PDGFR) kinase inhibitor; Vascular endothelial growth factor (VEGF) receptor inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today